Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Expression in Extranodal NK/T-Cell Lymphoma

被引：0
|
作者：
Jung, Ho Young
Kim, Wook Youn
Kim, Tae Min
Heo, Due Seog
Kim, Chul-Woo
Jeon, Yoon Kyung
机构：
[1] Konkuk Univ Sch Med, Seoul, South Korea
[2] Seoul Natl Univ Coll Med, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1410
引用
收藏
页码：353A / 353A
页数：1
相关论文
共 50 条
  • [41] Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications
    Wolkow, Natalie
    Jakobiec, Frederick A.
    Afrogheh, Amir H.
    Eagle, Ralph C., Jr.
    Pai, Sara, I
    Faquin, William C.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 200 : 226 - 241
  • [42] Association of disease activity with programmed cell death 1 and its ligand programmed cell death ligand 1 expressions in lupus patients
    Eissa, Eman
    Kandil, Rania
    El-Ghobashy, Nehal
    Abdelfattah, Walaa
    Hammouda, Zainab
    Gadelsayed, Sara Medhat
    Bayoumi, Faten
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (04) : 347 - 352
  • [43] Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma
    Todoroki, Keita
    Abe, Yushi
    Matsuo, Katsuhisa
    Nomura, Hidetoshi
    Kawahara, Akihiko
    Nakamura, Yoshiaki
    Nakamura, Moriyoshi
    Seki, Naoko
    Kusukawa, Jingo
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [44] Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro
    Tay, Woan Ting
    Fang, Yi-Hsien
    Beh, Suet Theng
    Liu, Yen-Wen
    Hsu, Ling-Wei
    Yen, Chia-Jui
    Liu, Ping-Yen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [45] PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION AND ASSOCIATION WITH SURVIVAL IN MESOTHELIOMA
    Mansfield, A. S.
    Peikert, T.
    Roden, A.
    Krco, C.
    Harrington, S.
    Dong, H.
    Kwon, E.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S50 - S50
  • [46] New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2017, 23 (01): : 10 - 22
  • [47] Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma
    Kyu Sang Lee
    Kyoungyul Lee
    Sumi Yun
    Seyoung Moon
    Yujun Park
    Jung Ho Han
    Chae-Yong Kim
    Hye Seung Lee
    Gheeyoung Choe
    Journal of Neuro-Oncology, 2018, 136 : 453 - 461
  • [48] Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma
    Lee, Kyu Sang
    Lee, Kyoungyul
    Yun, Sumi
    Moon, Seyoung
    Park, Yujun
    Han, Jung Ho
    Kim, Chae-Yong
    Lee, Hye Seung
    Choe, Gheeyoung
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (03) : 453 - 461
  • [49] Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
    Li, Chia-Wei
    Lim, Seung-Oe
    Xia, Weiya
    Lee, Heng-Huan
    Chan, Li-Chuan
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Chang, Shih-Shin
    Cha, Jong-Ho
    Kim, Taewan
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Ding, Qingqing
    Wang, Yan
    Yao, Jun
    Lee, Cheng-Chung
    Wu, Hsing-Ju
    Sahin, Aysegul A.
    Allison, James P.
    Yu, Dihua
    Hortobagyi, Gabriel N.
    Hung, Mien-Chie
    NATURE COMMUNICATIONS, 2016, 7
  • [50] Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
    Zhang, Ni
    Tu, Jingyao
    Wang, Xue
    Chu, Qian
    IMMUNOTHERAPY, 2019, 11 (05) : 429 - 441
12345